Stem Cells Press Release
|06/17/2020 - 20:18||
Yale scientists solve a thorny problem
Their insight, reported in the June 18 issue of Current Biology , may help change the way oranges and other crops are grown.
|06/15/2020 - 18:08||
UCLA receives nearly $14 million from NIH to investigate gene therapy to combat HIV
UCLA researchers and colleagues have received a $13.65 million grant from the National Institutes of Health to investigate and further develop an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy HIV.
|06/14/2020 - 22:05||
Stem Cells Without Ethical Implications Are Ready for the Spotlight
The global market for induced pluripotent stem cells (iPSCs), should reach $3.8 billion, growing 9.2% annually, according to the latest report by BCC Research, Induced Pluripotent Stem Cells: Global Markets .
|06/11/2020 - 17:11||
Two new, powerful small molecules may be able to kill cancers that other therapies cant
DUARTE, Calif. — City of Hope scientists have identified and developed two potent small molecules that appear to suppress tumor growth in multiple cancers even when other treatments cease to work, possibly due to the development of drug resistance.
|City of Hope Na...|
|06/10/2020 - 15:44||
Yale researchers find potential treatment for Rett syndrome
An experimental cancer drug can extend the life of mice with Rett syndrome, a devastating genetic disorder that afflicts about one of every 10,000 to 15,000 girls within 6 to 18 months after birth, Yale researchers report June 10 in the journal Molecular Cell.
|06/08/2020 - 03:57||
National honours shine a spotlight on UQ scientists
A quartet of top scientists is among members of The University of Queensland community to be recognised in the 2020 Queen’s Birthday Honours.
|06/04/2020 - 13:31||
How cells solve their identity crisis
LA JOLLA—Cancer is often the result of DNA mutations or problems with how cells divide, which can lead to cells “forgetting” what type of cell they are or how to function properly. Now, Professor Martin Hetzer and a team of scientists have provided clarity into how new cells remember their identity after cell division. These memory mechanisms, published in Genes & Development on June 4, 2020, could explicate problems that occur when cell identity is not maintained, such as cancer.
|06/02/2020 - 11:24||
Lab-Grown Miniature Human Livers Transplanted into Rats
PITTSBURGH, June 2, 2020 – Using skin cells from human volunteers, researchers at the University of Pittsburgh School of Medicine have created fully functional mini livers, which they then transplanted into rats.
|06/02/2020 - 10:19||
CSL Behring and Seattle Childrens Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases
SEATTLE and KING of PRUSSIA, Pa. – Jun e 02, 2020 - Seattle Children’s Research Institute, one of the top pediatric research institutions in the world, and global biotechnology leader CSL Behring announced a strategic alliance to develop stem cell gene therapies for primary immunodeficiency diseases.
|05/24/2020 - 23:37||
Three UWA scientists named Fellows of the Australian Academy of Science
Three top science, technology, engineering and mathematics (STEM) researchers from The University of Western Australia have been elected as 2020 Fellows of the Australian Academy of Science. They make up the total number of scientists representing WA from 24 Australians elected as Fellows this year.
|05/19/2020 - 03:10||
Four researchers awarded for doctoral dissertations of outstanding merit
The University of Helsinki doctoral dissertation awards for 2019 were bestowed to Erika Palmerio , Iris Sevilem , Aleksia Vaattovaara and Santeri Vanhanen .
|05/18/2020 - 05:00||
Athersys Announces Upcoming Presentations at the International Society of Cell and Gene Therapy Virtual Conference
Company will participate in three events at the largest global translation-focused cell and gene therapy meeting.
|05/15/2020 - 06:26||
Exploring diseases' sex differences, new uses for old drugs in treating COVID-19, a new perspective on brain tumor cells, and more
Welcome to the May 15, 2020 installment of Research Roundup , a recurring snapshot of recent studies published by scientists at the Broad Institute and their collaborators.
|05/15/2020 - 05:23||
CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
T he governing Board of the California Institute for Regenerative Medicine (CIRM) today approved new clinical trials for COVID-19 and sickle cell disease (SCD) and two earlier stage projects to develop therapies for COVID-19.
|05/14/2020 - 23:06||
GlycoMimetics to Present New Preclinical Data Highlighting Biomarkers and Potential Expanded Pipeline Opportunities at Virtual AACR Annual Meeting 2020
During the June session, GlycoMimetics will present preclinical data that further support the potential of the Company’s compounds to be used in the treatment of acute myeloid leukemia (AML) as well as in the setting of stem cell transplantation. Additionally, new information will be presented on the ability of transcriptome profiling to identify those tumor types most likely to benefit from targeted E-selectin inhibition, a key mechanism of GlycoMimetics drug candidates, supporting their potential uses in a biomarker-driven approach.
|05/14/2020 - 14:22||
Athersys to Present at the Bank of America Merrill Lynch Virtual Healthcare Conference on May 14
CLEVELAND--( )-- Athersys, Inc. (NASDAQ: ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the Bank of America Merrill Lynch 2020 Virtual Healthcare Conference to investors and analysts. The presentation is scheduled for Thursday, May 14, 2020 at 8:20 a.m.
|05/14/2020 - 13:41||
FDA approves COVID-19 trial after successful emergency use of umbilical stem cells from RESTEM
CORONA, Calif. , and MIAMI and SIOUX FALLS, S.D. , May 14, 2020 / / -- RESTEM, a leading cell-based therapeutics company, announced today it has received approval from the U.S. Food and Drug Administration (FDA) for a 60-patient Phase I/IIa study using umbilical cord mesenchymal stem cells to treat patients with severe cases of COVID-19. The study will be the first of its kind in the U.S.
|05/14/2020 - 11:53||
New research into stem cell mutations could improve regenerative medicine
New research from the University of Sheffield into stem cells could help make regenerative medicine safer Regenerative medicine involves using pluripotent stem cells to repair damaged or diseased tissues in the body The new research has suggested ways to reduce the likelihood of mutations occurring in these cells when cultured.
|05/14/2020 - 10:02||
Adventures in Organ LR Asymmetry: Role of Pitx2 in Gut Lymphatic Development and Lipid Transport Function
Other Tri-Institutional Events Natasza Kurpios, Ph.D., Associate Professor, Department of Molecular Medicine, Cornell University College of Veterinary Medicine.
|05/14/2020 - 08:19||
Tolero Pharmaceuticals Announces Expansion of the Zella 102 Study in Patients with Intermediate and High-Risk Myelodysplastic Syndromes (MDS)
First Patient Dosed with Optimized One-Hour Dosing Schedule for Investigational Agent Alvocidib After Azacitidine.
|05/14/2020 - 07:02||
Geron Announces Four Imetelstat Presentations at the Virtual Edition of the European Hematology Association Annual Congress
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that four abstracts containing new clinical data and analyses related to imetelstat, the Company’s first-in-class telomerase inhibitor, have been accepted for presentation at the Virtual Edition of the European Hematology Association (EHA) Annual Congress to be held online from June 11-14, 2020. The abstracts are available on the EHA website at www.ehaweb.org/congress.
|05/12/2020 - 16:00||
Mice with patchy coats lay bare how stem cells endure
Mice deficient in NFIB and NFIX have degenerated follicles (green ovals) and an unusually thick skin (red).
|05/12/2020 - 12:39||
National Cancer Institute Renews Jackson Laboratorys Cancer Center Designation
For the price of a coffee or a monthly streaming service, you can invest in changing the future of human health every day.
|05/11/2020 - 21:37||
Commuting to the Lab during a Pandemic: Meet the Scientists Who Are Studying COVID-19
These are just some of the Gladstone scientists who have volunteered to go to the lab to study coronavirus.
|05/11/2020 - 10:01||
An interdisciplinary team of researchers at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA has developed a first-of-its-kind roadmap of how human skeletal muscle develops, including the formation of muscle stem ce
The study, published May 11 in the peer-reviewed journal Cell Stem Cell, identified various cell types present in skeletal muscle tissues, from early embryonic development all the way to adulthood. Focusing on muscle progenitor cells, which contribute to muscle formation before birth, and muscle stem cells, which contribute to muscle formation after birth and to regeneration from injury throughout life, the group mapped out how the cells’ gene networks — which genes are active and inactive — change as the cells mature.